✦ LIBER ✦

Acute challenge ERP as a prognostic of stimulant therapy outcome in attention-deficit hyperactivity disorder

✍ Scribed by Edwin Sinclair Young; Peter Perros; Greg W. Price; Trevor Sadler

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost Effectiveness of Guanfacine Extende

✍ Dr Vanja Sikirica PharmD, MPH, M. Haim Erder, Jipan Xie… 📂 Article 📅 2012 🏛 Springer International Publishing AG 🌐 English ⚖ 204 KB

A Modeled Economic Evaluation Comparing

✍ Suzi Cottrell; Dominic Tilden; Paul Robinson; Jay Bae; Jorge Arellano; Eric Edge 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 304 KB

Comorbidity as a predictor and moderator

✍ Thomas H. Ollendick; Matthew A. Jarrett; Amie E. Grills-Taquechel; Laura D. Hove 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 417 KB

PMH36 A COST-UTILTY ANALYSIS OF ATOMOXET

✍ A Diamantopoulos; M Lorenzo; M Happich; S Cottrell; H Scheijbeler 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

PIH23 Cost-Effectiveness of Guanfacine E

✍ V. Sikirica; M. Erder; J. Xie; D. Macaulay; M. Diener; P. Hodgkins; E.Q. Wu 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB